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Introduction: Paediatric respiratory tract infections
(RTIs) are common reasons for primary care
consultations and antibiotic prescribing. Locally
relevant syndromic and microbiological surveillance
information has the potential to improve the care of
children with RTIs by normalising illness (parents) and
reducing uncertainty (clinicians). Currently, most RTI
studies are conducted at the point of healthcare service
consultation, leaving the community burden,
microbiology, symptom duration and proportion
consulting largely unknown. This study seeks to
establish the feasibility of (mainly online) participant
recruitment and retention, and the acceptability/
comparability of parent versus nurse-collected
microbiological sampling, to inform the design of a
future surveillance intervention study. Evidence
regarding consultation rates and symptom duration is
also sought.
Methods and analysis: A community-based,
feasibility prospective inception cohort study, recruiting
children aged ≥3 months and <16 years and their
parents via general practitioner surgery invitation letter,
aiming to collect data on 300 incident RTIs by July
2016. Following informed consent, parents provide
baseline (demographic) data online, and respond to
weekly emails to confirm the absence/presence of new
RTI symptoms. Once symptomatic, parents provide
daily data online (RTI symptoms, school/day-care
attendance, time off work, health service use,
medication), and a research nurse visits to collect
clinical examination data and microbiological (nasal
and saliva) swabs. Parents are invited to provide
symptomatic (at nurse visit, but without nurse
assistance) and asymptomatic (alone) swabs on
recovery. A review of primary care medical notes will
gather medical history, health service utilisation,
referral and antibiotic prescribing rates. Feasibility will
be assessed using recruitment and retention rates, data
completeness; and acceptability by quantitative survey
and qualitative interviews. Symptomatic parent and
nurse swab pairs will be compared for microbe
isolation.
INTRODUCTION
General practitioners’ (GPs) workload is
increasing as primary care has seen a rise in
consultation rates (without corresponding
increase in GP staff time), and increased
complexity in patient cases over recent
years.1 Respiratory tract infections (RTIs) are
the most common problem managed by
primary care internationally, with the major-
ity occurring in children.2 Children experi-
ence on average 6–8 RTIs annually and NHS
costs and costs to parents and carers (here-
after termed ‘parents’) for paediatric RTIs
are signiﬁcant.3
Additionally, there is a growing public
health threat of increasing antimicrobial
resistance (AMR),4 largely attributed to the
overprescription of antibiotics.5 The use of
primary care services for RTIs and antibiotic
prescribing are inseparable; primary care is
responsible for nearly 80% of antibiotics pre-
scribed6 and 54% of patients with RTI are
given antibiotics.7 Owing to the large
Strengths and limitations of this study
▪ Near exclusive online methods to recruit and
follow-up children with respiratory tract infec-
tions not yet brought to the attention of health-
care services.
▪ Will provide evidence of the feasibility of con-
ducting larger scale community-based studies.
▪ Will provide novel evidence regarding the natural
history of RTI symptoms in a non-consulting
paediatric population.
▪ Will provide novel evidence regarding the propor-
tion of children consulting within any given
illness episode.
▪ Representativeness of study participants may be
limited by low response to study invitation.
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numbers, even a small change in consultation rates and
improved targeting of antibiotic prescribing for paediat-
ric RTIs could have a signiﬁcant impact on primary care
resources and help reduce AMR.
A key element of the problem is uncertainty felt by
parents and clinicians. In parents, uncertainty exists in
understanding their child’s illness (eg, normal symptoms
and duration), appropriate care and when to consult.7–9
In clinicians, uncertainty exists regarding diagnosis and
effective treatment of RTIs in primary care, indicated by
the variation in antibiotic prescribing between clini-
cians,10 and surgeries.6 GPs tend towards prescribing
antibiotics in the face of uncertainty for paediatric RTIs,
due to a perception that not prescribing carries greater
potential threat.11
The Chief Medical Ofﬁcer’s 2011 Annual Report iden-
tiﬁes a need for enhanced surveillance of infectious dis-
eases, with a focus on tackling AMR and improving
antibiotic stewardship, and recommends research to
enhance infectious disease surveillance.12
Currently available UK healthcare-based infection sur-
veillance information includes microbiology data pre-
sented in weekly laboratory reports from the Public
Health England (PHE) based on swabs predominantly
received from secondary care. These data are not cur-
rently routinely provided to GPs as an informational
resource. Syndromic surveillance is also underway via
PHE weekly summaries of broad syndromic illnesses pre-
senting to healthcare services (primary and secondary
care). There is an absence of matched microbiology and
syndromic data, and an absence of community infection
data of any kind, much less community paediatric RTI
data. Enhanced surveillance can provide these data,
which could better inform clinical judgement when
dealing with this highly prevalent patient population.
Community participation in illness surveillance (via
real-time online symptoms self-report) has been success-
fully applied to inﬂuenza in adults—for example,
Gripenet13 and the FluSurvey project,14 though the
majority of this work to date has been based on
symptom self-report, and lacks associated microbio-
logical data to identify circulating pathogens.
Improving the availability of surveillance data on com-
munity RTIs, including the microbiology matched with
syndromic presentation, has the potential to reduce clin-
ician uncertainty and improve the targeted use of anti-
biotics and appropriate secondary care referrals. It may
also improve clinicians’ ability to reassure patients, spe-
ciﬁcally since parents ﬁnd that commonly used micro-
biological diagnoses (eg, ‘it’s just a virus’) in the absence
of microbiological evidence undermine clinician cred-
ibility.7 The availability to parents of community infec-
tion surveillance data is hypothesised to have potential
to decrease parental anxiety and encourage home man-
agement of RTIs, thereby reducing consultation burden.
Additionally, previous research has focused on paediat-
ric RTIs captured during primary care presentation.15 16
This leaves a key area of uncertainty regarding
community paediatric RTIs. Duration, symptoms and
proportion seen in primary care are not known, nor is
the relative contribution of socio-demographic, clinical
and microbiological factors to primary care consultation
for RTIs. Our study will be able to provide some answers
to these questions by collecting prospective data on
paediatric RTIs in the community as well as presenting a
comparison of the duration of RTI symptoms between
consulting and non-consulting children, which has
potential for informing other interventions (beyond the
planned surveillance intervention to be built from this
study).
Aim
The primary aim is to assess the feasibility of assembling
a non-consulting inception cohort from whom paediat-
ric RTI microbiological and symptomatic surveillance
data are collected. The purpose is to inform the design
of future surveillance studies and interventions, with the
overarching objective to improve primary care utilisa-
tion, and antibiotic prescribing for paediatric RTI.
Secondary aims are to provide evidence regarding the
proportion choosing to consult for reported symptoms




An invitation was sent to all GP surgeries within a 10
mile radius of Bristol City Centre via the NIHR Clinical
Research Network (CRN), West of England. Nineteen
surgeries expressed interest, of which 10 reached and
conﬁrmed agreement with the study team to take part
(ﬁgure 1). Efforts were made to source GP surgeries
across a range of areas of deprivation.
Participant screening and exclusion
GP practices were asked to run database searches with
ﬁlters to exclude: children aged under 3 months or over
15 years; children with life-limiting (terminal) illness
(for whom a study invitation could cause distress); those
with a health condition giving greater risk of serious
infection; and temporary (as opposed to fully registered)
patients. GP surgery staff further screened lists to
remove: children resident in households for which a
study invitation could cause stress to the parents (eg,
recent bereavement or terminal illness in the family); or
which may present a risk for a research nurse (RN) or
interviewer conducting a lone home visit (eg, history of
domestic violence).
The process for letter invitation to take part involved
uploading the ﬁnal patient list to an online mailing
company, which sent an invitation letter addressed ‘to
the parent/carer of [name of child]’ together with an
information leaﬂet, consent form and FREEPOST reply
envelope addressed to the study team. All children aged
7 or older by September 2015 (the equivalent of UK
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Figure 1 Study recruitment and data collection flow chart. Blue box indicates main study processes for enrolled participants,
yellow boxes indicate participant actions to take, grey boxes indicate laboratory processing and orange boxes indicate interviews
(optional).
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school year 3 and above) also received a children’s infor-
mation leaﬂet, and assent form to sign.
Parents return signed consent (and assent) forms to
the study team using pre-paid envelopes. On receipt of
consent, the study team conﬁrm eligibility over the tele-
phone to enrol children into the study and initiate
online data collection. In addition to the exclusion cri-
teria above, children are excluded if: the parent lacks
capacity to consent; or lacks adequate English language
understanding to complete study processes or other
reasons (eg, family away during data collection phase).
Supplementary recruitment efforts
Attempts were made to maximise response rates through
supplementing the initial letter mailout with non-
responders receiving a reminder letter and (where the
GP surgery had the facility) text (texts were not sent to
the mobile numbers associated with older children’s
medical records due to the risk of the number being the
child’s own phone rather than the parents, who are the
consenting participants). In addition, posters and
recruitment cards were displayed in all GP surgeries; the
team released a press release and set up a study website
encouraging recruitment. Recruitment cards were also
sent to all families identiﬁed as eligible during their
welcome call, with a request to pass the message on to
other parents who may be interested in the study (for
‘snowball’ recruitment).
Families, children and incident RTIs
The event of interest are new RTIs, developing after
study recruitment. Participants are children registered at
participating GP surgeries, while parents are the main
point of contact for study participation, since they
provide consent and data for the participating children.
Children aged 7 by September 2015 (equivalent to UK
school year 3) or older provide assent prior to participa-
tion. A subsample of participating parents and children
will be interviewed, as well as a subsample of clinicians
from participating GP surgeries.
GP surgeries provide basic, anonymised information
regarding non-responders (gender and age of children)
and a measure of index of multiple deprivation (IMD)
for comparison with the recruited cohort. Recruiting via
GP surgeries therefore brings the beneﬁt of enabling
some assessment of how representative the recruited
cohort is for each surgery.
Sample size
The study is set up to provide descriptive results to
inform the design of future community surveillance and
intervention studies. In this context, recruitment and
retention are the primary outcomes of this feasibility
study. Incident RTIs developing before mid-July 2016 is
the unit of analysis, deﬁned as parent-reported new RTI
symptoms (blocked/runny nose, earache/ear discharge,
sore throat, cough or chesty symptoms—over and above
normal). A sample size of 300 incident RTIs is set as an
aim, as a potentially attainable number based on prac-
tical considerations (ﬁgure 2).
In addition to retention and recruitment rates, the
study will address two main secondary aims, with statis-
tical calculations outlined below:
1. How many children with RTI consult?
2. What is the duration of the RTI symptoms in the
community?
3. Consultation rate: Approximately 20% of adults with
RTI in the community consult with a clinician,17
while equivalent rates in children are unknown (a
research gap that this study addresses). With a
sample size of 300 RTI, we could expect a 95% CI of
±5% (15% to 25%) around a 20% point estimate for
consultation rates.
4. Duration of symptoms: We could expect a 95% CI of
87% to 93% around an estimate of 90% for the pro-
portion recovered at the relevant time point, using an
exact binomial calculation (using the same methods
used for Hay et al’s18 study on cough duration).
Figure 2 shows a ﬂow chart of projected recruitment
numbers based on conservative estimates of 80% of
recruited children developing at least one RTI over the
study period,2 20% parent attrition rate after study enrol-
ment and that each parent will contribute data for just
one episode in one child only rather than opting to con-
tinue in the study beyond this. By these calculations, we
would need to recruit a total of 457 parents to take part
in the study, or 777 children (based on an average 1.7
dependent children per UK household).19 Based on
previous similar research by the wider group, mailout
response rate was expected to be 5%.
Outcomes
Primary outcome
The primary outcome is recruitment and retention.
Recruitment rates are the number of incident RTIs
reported in the study (and the proportion of these per
total recruited children/families). Retention is mea-
sured as the number of incident RTI episodes in the
study with a reported recovery date (deﬁned as two con-
secutive symptom-free days), to be presented with a
descriptive analysis of missing data
The main secondary outcomes are:
1. Primary and secondary care consultation rates as a
proportion of reported episodes of RTI symptoms.
2. Duration of RTI symptoms, including a comparison
between consulting and non-consulting children.
Further secondary outcomes:
1. RTI numbers contributed per child and per house-
hold (ie, including enrolled siblings).
2. Subassessment of rates of retention in the study (eg,
agreeing to ongoing symptoms trigger texts/emails)
after completion of one RTI episode data; response
rates to weekly emails.
3. Representativeness of study sample via comparison
of responders with non-responders to GP surgery
invitation letter with respect to family deprivation
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level assessed via IMD (derived from parent address
postcode and GP practice population, respectively).
4. Completion rates of survey questions including: use
of primary and secondary care services for RTIs prior
to RTI symptom resolution; prescribing and con-
sumption of antibiotics; parental health anxiety;
parent conﬁdence in managing children’s minor
illness; adverse events (AEs); costs to the NHS (eg,
cost of consultations and prescriptions) and the
family (eg, over the counter medicines) and conse-
quences (eg, time off school/nursery, time off work),
with preliminary statistical analysis of these data.
5. Factors associated with decisions to consult (mea-
sured directly via free-text response to the online
survey question ‘what triggered that decision’, eli-
cited on parent report of consulting for incident
RTI; together with a descriptive analysis of other
factors including parent-reported health-anxiety and
household demographics).
6. Cost of feasibility study with scaled up cost estimate
of a deﬁnitive cohort study with real-time online syn-
dromic/microbiological surveillance intervention.
7. Acceptability of study processes (eg, online surveys
and swab sampling), collected via parent and chil-
dren interviews and supplemented by parent survey
(asking for 5-point Likert scale response to how user-
friendly parents found the online questionnaire;
‘very’ to ‘not at all’ with optional free text box).
8. Attitudes towards the informational content, design
and perceived potential impact of infection surveil-
lance information, collected via parent and clinician
interviews (based on presentation of mock-up
example data) to inform intervention design and
development.
9. Agreement of microbiological detection between:
▸ Nasal swabs versus saliva samples (as κ statistic);
▸ Parent-collected and posted nasal swabs com-
pared with ‘gold standard’ RN-collected nasal
swabs (as κ statistic);
▸ Parent-collected and posted saliva samples com-
pared with ‘gold standard’ RN-collected saliva
samples (as κ statistic).
10. Difference in microbiological presence and load
(cycle threshold values) between symptomatic and
asymptomatic samples as a matched comparison
with each RTI case, using paired t-tests/Wilcoxon
signed-rank tests.
Data collection
Figure 1 shows the study recruitment and data collection
ﬂow chart, with details of the data to be collected out-
lined below. Parent-reported data are collected using an
online database, designed and built speciﬁcally for the
study, which provides survey links and reminders to
parents via automated emails.
1. Baseline data (collected online prior to ﬁrst study
RTI): Parent, child and household demographics
(including ethnicity of parent and child, parent
employment status and educational level, ages of
members of the household) and optional parent
health anxiety/conﬁdence scales.
2. Incident RTIs (<7 days of symptom onset): Parents are
emailed weekly and asked to conﬁrm (simple Y/N
response) if each child has developed: blocked/
runny nose, earache/ear discharge, sore throat,
cough or chesty symptoms in the last 7 days over and
above what is normal for them. A ‘Y’ response elicits
a symptoms and recovery survey for the parent to
complete online (via smartphone, tablet or com-
puter) to record symptom start date and ongoing
daily symptoms.
3. Microbiological sampling: A ‘Y’ response also prompts
the RN to arrange a home visit while the child is
symptomatic for clinical examination of the child and
to collects a set of saliva and nasal swabs from the
child, transported via preservative broth in collection
tubes immediately to the laboratory (‘gold standard’
sampling). The RN also asks the parent to take a
Figure 2 Study recruitment and
retention projection.
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saliva and nasal swab from the child during the visit,
using dry collection tubes and post these to the
laboratory. Laboratory analysis of swab samples uses
PCR on an array of common respiratory tract viruses
and bacteria.
4. Follow-up RTI data: Parents are asked to continue to
complete an online symptoms diary to record: RTI
symptoms and severity until illness resolution (two
consecutive RTI symptom-free days), and impact of
the illness (school/day-care attendance; time off
work; symptomatic status of household members,
primary care consultation, antibiotic consumption
and other medication use). Daily symptoms data are
collected for a maximum of 21 days. If symptoms are
ongoing beyond 21 days, data collection reverts to a
weekly online questionnaire up to a maximum of
8 weeks from the date of ﬁrst RTI symptom presenta-
tion. Following symptom resolution, the parent can
choose to opt in or out of continuing to participate
in the study with the same child or any other chil-
dren in the household (ie, resume receiving weekly
emails in the case of further RTI development in a
child). Reminders for diary completion are via an
automated email sent every 2 days. Complementary
telephone calls encourage survey completion if
missing data lags for more than a week.
5. Asymptomatic sample: As soon as possible after
symptom resolution, the parent is asked to collect a
saliva and a nasal swab (without RN visit) to post to
the laboratory for PCR analysis as a matched case
comparison, and to complete a ﬁnal online swabs col-
lection survey (to conﬁrm presence, if any, of symp-
toms at the time of swab collection, date of collection
or reason for non-collection of samples).
6. Follow-up primary care notes data: will record primary
care RTI consultations and antibiotic prescribing
during the RTI, as well as secondary care referrals or
contacts, and diagnostic information relating to RTI
(conducted on all children contributing RTI data to
the study; collected at the end of the ‘live’ data col-
lection period). Relevant medical history will also be
extracted to supplement baseline data.
7. Parent (and child) interviews (planned n=30): Of the
parents who (on study enrolment) consented to an
interview, a maximum diversity sample will be invited
for one face-to-face semistructured interview (at
parent’s home or convenient location). These inter-
views aim to understand parent and child experi-
ences and acceptability of the study components as
well as gaining feedback on the content and utility of
the planned intervention.
8. Clinician interviews (planned n=24): Clinicians in par-
ticipating GP practices will be invited for 130 min
semistructured interview (in person/via telephone)
to gain feedback on the acceptability and potential
impact of the planned intervention.
DATA ANALYSIS PLAN
As this is a feasibility study, we will present simple
descriptive results. The main outcome, recruitment and
retention rates, will be presented with a descriptive ana-
lysis of missing data.
We will describe the characteristics (to include age,
comorbidities and ethnicity) of the children and house-
holds in the study (means and SDs will be presented for
normally distributed variables, medians and IQRs will be
presented where variables are non-normally distributed,
and percentages presented for categorical variables).
Descriptive characteristics of similar variables (as avail-
able from GP database search outputs) will be presented
for the GP surgery populations from which we recruited
(for sample representativeness and response rates).
Analysis of primary outcome
We will assess whether our outcome (recruitment and
retention) is associated with particular baseline
characteristics, for example, does response completion
vary by postcode index of deprivation or household
crowding? Is age, gender or ethnicity of the child or
parent related to response rate? As our primary outcome
is represented by binary variables: we will use χ2 tests,
t-tests and univariable logistic regression to estimate asso-
ciations of baseline characteristics with outcome.
Regression analyses will be adjusted for clustering (chil-
dren within families within GPs) where appropriate.
Analysis of secondary outcomes
Similar strategies will be used for the secondary out-
comes and linear regression will be used where the
outcome is continuous, for example, duration of RTI
symptoms. Again, regression analyses will be adjusted for
clustering where appropriate.
We will use κ statistics to assess the level of agreement
between different methods of collecting swabs. If we
consider the RN-collected swabs to be the gold standard,
then we can assess the diagnostic utility of the parent-
collected swabs by calculating sensitivity and speciﬁcity.
We will also consider whether the quantity of microor-
ganisms present differs according to the collection site
(nasal or mouth) by calculating correlation coefﬁcients
and limits of agreement for the Bland-Altman plots.
All statistical analyses will be completed using Stata
V.14 (StataCorp. Stata Statistical Software: College
Station, Texas: StataCorp LP, 2015).
Interview data will be audio recorded using encrypted
devices, transcribed verbatim and analysed via NVivo
V.10 using the framework method.20
ETHICS AND DISSEMINATION
Ethical considerations
The study is low risk in terms of ethical issues. Children
will not be receiving a medication or intervention, and
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no treatment is withheld. The cost to parents is mainly
in the time taken to ﬁll in questionnaires and a potential
‘burden’ of reading and responding to regular emails.
A patient and public involvement (PPI) group of Bristol
parents were consulted several times during the study
design to ensure the paperwork, surveys and procedures
were likely to be acceptable. Participants who develop an
RTI, complete symptom diaries and provide swab
samples will receive a £15 high street voucher as a thank
you gift for their time. Parents who take part in the
interview study will receive an extra £5 voucher.
Patient safety
Patient safety takes highest priority throughout all study
procedures.
Nasal swab-taking by parents may cause minor distress
either to parents or to the child, but are not likely to cause
physical harm. Saliva sample-taking is an unobtrusive
process with very low likelihood of causing any distress.
The study team provides clear instructions and support
(if necessary) for parents on swab-taking. The RN proce-
dures (taking saliva and nasal swab and a clinical examin-
ation) are routine procedures, undertaken by experienced
professionals. In the event of signiﬁcant child or parent
distress around the process, no swabs or examination are
to be taken. RNs act according to clinical expertise and
NHS guidelines when conducting visits to prioritise
patient safety. In the event that the RN, on assessing the
child, is concerned about the health of the child, they may
advise that the parent seeks medical advice (recording this
as a possible study-induced primary care visit).
Participants retain the right to withdraw from the study
at any time, with an additional right to request destruc-
tion of existing data or samples collected from them.
Research staff safety
Home visits conducted by RN and qualitative interview
staff are guided by the University of Bristol safety policy
for researchers working in the ﬁeld.21 A lone worker
policy is applied for all ﬁeldwork in accordance with
University of Bristol guidance.22
Study conduct
RNs and all the research team are DBS checked for par-
ticipant safety measures (according to the principles of
GCP).
Medical notes review will be undertaken by research
staff with honorary NHS contracts and the process will
be conducted according to NHS and research standards
on conﬁdentiality and ethical practice.
Safety (AEs)
Any unexpected AEs deﬁned as ‘any untoward medical
occurrence in a study participant’ and serious adverse
events (SAEs) will be monitored by the study team for
seriousness, causality and expectedness, and these will
reviewed at management group meetings.
An SAE is deﬁned as any untoward and unexpected
medical occurrence or effect that: results in death; is
life-threatening (refers to an event during which the par-
ticipant was at risk of death at the time of the event; it
does not refer to an event which might have caused
death had it been more severe in nature), requires hos-
pitalisation, or prolongation of existing hospitalisation;
results in persistent/signiﬁcant disability or incapacity; is
a congenital abnormality or birth defect.
AE procedure
In the event that a research team member is informed
of a hospitalisation or other SAE occurring within the
active participation phase of the study, the research team
member will record relevant information about the inci-
dent, including whether the study was in any way linked
to the outcome. The research team member initially col-
lecting this information will report the incident to the
PI and/or study manager within 24 hours of its discovery
(in accordance with usual SAE procedures). If there is
any indication that an SAE could have been linked to
study procedures (eg, a child inhaling a saliva sample),
it will provoke a research team-led investigation, with
reporting to the sponsor via the usual procedures as
detailed on the University of Bristol Research and
Enterprise Development website.23
Around 1% of children presenting to primary care
with RTI are likely to be hospitalised.24 With a sample of
300 RTI episodes, a generous allowance of up to
one-third of children with RTI presenting to primary
care would anticipate that just one child may be hospita-
lised for their RTI within the study duration.
All expected SAEs will be reported as part of the
outcome of the study.
Dissemination plan
The written papers from this work will be submitted for
publication in quality peer-reviewed health journals.
There will be a main feasibility study paper which will
inform the design of future cohort and intervention
studies. Owing to their novelty, we anticipate that sec-
ondary study results will be publishable as separate
papers, for example, the clinical utility and cost of com-
munity swab types; RTI duration in the community and
numbers of children consulting; microbiological (and
symptoms) proﬁling of RTIs (with possible future trans-
mission modelling); contribution of socio-demographic,
clinical and microbiological factors to NHS use; qualita-
tive papers describing parent and clinician views of a
microbiological information intervention. Application
will be made to present study results at relevant
conferences.
Study participants will receive a newsletter outlining
the main study results. The PPI group will advise on
parent newsletter content and dissemination.
Participating GPs will also receive a newsletter about the
results. These newsletters will include a link to the study
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website where we will post further information and links
to papers when accepted for publication.
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